Popular Articles
Teeth Whitening

Intestinal Inflammation Linked To Systemic Chromosome Damage
UCLA scientists have linked for the first time intestinal inflammation with systemic chromosome damage in mice, a finding that may lead to the early identification and treatment of human inflammatory disorders, some of which increase risk for several types of cancer.
generic viagra online
MAP Pharmaceuticals Phase 3 Trial Of Levadex™ Migraine Product Candidate Meets All Four Primary Endpoints
MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) announced that the efficacy portion of its first Phase 3 clinical trial evaluating its novel LEVADEX™ orally inhaled migraine therapy met all four primary endpoints. Additional endpoints showed that LEVADEX provided rapid and sustained pain relief for up to 48 hours after dosing.
plastic surgery before after
News of the day
Infants Experience Errors In Heart Meds Most Often
Infants and young children treated with heart drugs get the wrong dose or end up on the wrong end of medication errors more often than older children, according to research led by the Johns Hopkins Children"s Center published July 6 in Pediatrics.
Health Insurance

All Fifty States To Screen Newborns For Cystic Fibrosis By 2010

The Cystic Fibrosis Foundation announced today that all 50 states, plus the District of Columbia, have passed legislation requiring that all newborns be screened for cystic fibrosis (CF) by the year 2010. Early diagnosis of cystic fibrosis, a life-threatening, genetic disease, can have a dramatic impact on the health of those born with the condition. Newborn screening for CF was adopted nationwide at a rapid pace, following the aggressive advocacy efforts of the Cystic Fibrosis Foundation, its volunteers and many local and national interest groups. In 2005, only five states required that CF be included on the list of mandatory screening conditions. After years of debate, Texas and Connecticut - the last two states without mandatory newborn screening - will now establish programs. Connecticut will begin screening Oct. 1, 2009, and Texas is expected to start in December. "We congratulate Texas and Connecticut for joining a nationwide effort to ensure that every child born with cystic fibrosis gets the best possible start in life," said Robert J. Beall, Ph.D., president and CEO of the Cystic Fibrosis Foundation. "Newborn screening is critically important for this disease because early diagnosis is tied to better health. We extend our thanks to every volunteer and advocate who fought to establish screening programs across the country." Research shows that newborn screening for CF likely improves and extends the lives of those born with the disease. Early diagnosis allows affected infants to begin therapeutic interventions immediately. Early treatment has been shown to improve height, weight, nutrition, cognitive and lung functioning, and to reduce hospitalizations. Cystic fibrosis affects approximately 30,000 children and adults in the United States and 70,000 people worldwide. It causes thick mucus to build up in the lungs and other organs, resulting in life-threatening infections and serious digestive complications. More than 10 million Americans are symptomless carriers of a cystic fibrosis gene. Most people who have a child with CF are not aware of a family history of the disease. When the Cystic Fibrosis Foundation was created in 1955, few children lived to attend elementary school. Today, as a result of dramatic improvements in research and care fueled by the Foundation, the median age of survival for a person with CF is more than 37 years. Cystic Fibrosis Foundation


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):